China · Delayed Price · Currency is CNY R&G PharmaStudies Statistics
Total Valuation
SHE:301333 has a market cap or net worth of CNY 4.69 billion. The enterprise value is 2.99 billion.
| Market Cap | 4.69B |
| Enterprise Value | 2.99B |
Important Dates
The next estimated earnings date is Friday, August 28, 2026.
| Earnings Date | Aug 28, 2026 |
| Ex-Dividend Date | Jul 8, 2025 |
Share Statistics
SHE:301333 has 95.99 million shares outstanding. The number of shares has decreased by -0.16% in one year.
| Current Share Class | 95.99M |
| Shares Outstanding | 95.99M |
| Shares Change (YoY) | -0.16% |
| Shares Change (QoQ) | -1.17% |
| Owned by Insiders (%) | 12.32% |
| Owned by Institutions (%) | 12.63% |
| Float | 28.41M |
Valuation Ratios
The trailing PE ratio is 34.90 and the forward PE ratio is 28.27.
| PE Ratio | 34.90 |
| Forward PE | 28.27 |
| PS Ratio | 5.24 |
| PB Ratio | 2.34 |
| P/TBV Ratio | 2.48 |
| P/FCF Ratio | 53.04 |
| P/OCF Ratio | 43.75 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 21.13, with an EV/FCF ratio of 33.78.
| EV / Earnings | 22.38 |
| EV / Sales | 3.34 |
| EV / EBITDA | 21.13 |
| EV / EBIT | 23.86 |
| EV / FCF | 33.78 |
Financial Position
The company has a current ratio of 6.01, with a Debt / Equity ratio of 0.00.
| Current Ratio | 6.01 |
| Quick Ratio | 5.83 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.05 |
| Debt / FCF | 0.08 |
| Interest Coverage | 47.53 |
Financial Efficiency
Return on equity (ROE) is 6.96% and return on invested capital (ROIC) is 41.39%.
| Return on Equity (ROE) | 6.96% |
| Return on Assets (ROA) | 3.34% |
| Return on Invested Capital (ROIC) | 41.39% |
| Return on Capital Employed (ROCE) | 6.14% |
| Weighted Average Cost of Capital (WACC) | 7.13% |
| Revenue Per Employee | 338,850 |
| Profits Per Employee | 50,530 |
| Employee Count | 2,645 |
| Asset Turnover | 0.38 |
| Inventory Turnover | 9.47 |
Taxes
In the past 12 months, SHE:301333 has paid 16.97 million in taxes.
| Income Tax | 16.97M |
| Effective Tax Rate | 11.18% |
Stock Price Statistics
The stock price has increased by +1.99% in the last 52 weeks. The beta is 0.52, so SHE:301333's price volatility has been lower than the market average.
| Beta (5Y) | 0.52 |
| 52-Week Price Change | +1.99% |
| 50-Day Moving Average | 61.69 |
| 200-Day Moving Average | 61.21 |
| Relative Strength Index (RSI) | 24.55 |
| Average Volume (20 Days) | 1,513,626 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:301333 had revenue of CNY 896.26 million and earned 133.65 million in profits. Earnings per share was 1.40.
| Revenue | 896.26M |
| Gross Profit | 298.35M |
| Operating Income | 125.33M |
| Pretax Income | 151.74M |
| Net Income | 133.65M |
| EBITDA | 128.01M |
| EBIT | 125.33M |
| Earnings Per Share (EPS) | 1.40 |
Balance Sheet
The company has 1.72 billion in cash and 7.04 million in debt, with a net cash position of 1.71 billion or 17.83 per share.
| Cash & Cash Equivalents | 1.72B |
| Total Debt | 7.04M |
| Net Cash | 1.71B |
| Net Cash Per Share | 17.83 |
| Equity (Book Value) | 2.00B |
| Book Value Per Share | 20.80 |
| Working Capital | 1.80B |
Cash Flow
In the last 12 months, operating cash flow was 107.32 million and capital expenditures -18.79 million, giving a free cash flow of 88.52 million.
| Operating Cash Flow | 107.32M |
| Capital Expenditures | -18.79M |
| Depreciation & Amortization | 2.68M |
| Net Borrowing | -18.87M |
| Free Cash Flow | 88.52M |
| FCF Per Share | 0.92 |
Margins
Gross margin is 33.29%, with operating and profit margins of 13.98% and 14.91%.
| Gross Margin | 33.29% |
| Operating Margin | 13.98% |
| Pretax Margin | 16.93% |
| Profit Margin | 14.91% |
| EBITDA Margin | 14.28% |
| EBIT Margin | 13.98% |
| FCF Margin | 9.88% |
Dividends & Yields
This stock pays an annual dividend of 0.16, which amounts to a dividend yield of 0.32%.
| Dividend Per Share | 0.16 |
| Dividend Yield | 0.32% |
| Dividend Growth (YoY) | -20.00% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 8.82% |
| Buyback Yield | 0.16% |
| Shareholder Yield | 0.48% |
| Earnings Yield | 2.85% |
| FCF Yield | 1.89% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on June 29, 2023. It was a forward split with a ratio of 1.6.
| Last Split Date | Jun 29, 2023 |
| Split Type | Forward |
| Split Ratio | 1.6 |
Scores
SHE:301333 has an Altman Z-Score of 10.1 and a Piotroski F-Score of 5.
| Altman Z-Score | 10.1 |
| Piotroski F-Score | 5 |